Are 0 3 0 3 O
undergoing 4 14 4 14 O
treatment 15 24 15 24 O
for 25 28 25 28 O
pancreatic 29 39 29 39 B-cancer
cancer 40 46 40 46 I-cancer
at 47 49 47 49 O
Fox 50 53 50 53 O
Chase 54 59 54 59 O
Cancer 60 66 60 66 O
Center 67 73 67 73 O

Have 0 4 74 78 O
an 5 7 79 81 O
Eastern 8 15 82 89 B-clinical_variable
Cooperative 16 27 90 101 I-clinical_variable
Oncology 28 36 102 110 I-clinical_variable
Group 37 42 111 116 I-clinical_variable
( 43 44 117 118 I-clinical_variable
ECOG 44 48 118 122 I-clinical_variable
) 48 49 122 123 I-clinical_variable
performance 50 61 124 135 I-clinical_variable
status 62 68 136 142 I-clinical_variable
of 69 71 143 145 O
0 72 73 146 147 B-lower_bound
, 73 74 147 148 O
1 75 76 149 150 O
, 76 77 150 151 O
or 78 80 152 154 O
2 81 82 155 156 B-upper_bound

Have 0 4 157 161 O
an 5 7 162 164 O
estimated 8 17 165 174 O
life 18 22 175 179 B-clinical_variable
expectancy 23 33 180 190 I-clinical_variable
of 34 36 191 193 O
greater 37 44 194 201 O
than 45 49 202 206 O
3 50 51 207 208 B-lower_bound
months 52 58 209 215 I-lower_bound

Have 0 4 216 220 O
borderline 5 15 221 231 B-cancer
resectable 16 26 232 242 I-cancer
or 27 29 243 245 O
unresectable 30 42 246 258 O
locally 43 50 259 266 O
advanced 51 59 267 275 O
disease 60 67 276 283 O
or 68 70 284 286 O
metastatic 71 81 287 297 B-cancer
disease 82 89 298 305 I-cancer

Have 0 4 306 310 O
histologically 5 19 311 325 O
confirmed 20 29 326 335 O
adenocarcinoma 30 44 336 350 B-cancer
of 45 47 351 353 I-cancer
the 48 51 354 357 I-cancer
pancreas 52 60 358 366 I-cancer

Inability 0 9 367 376 B-language_fluency
to 10 12 377 379 I-language_fluency
communicate 13 24 380 391 I-language_fluency
in 25 27 392 394 I-language_fluency
English 28 35 395 402 I-language_fluency

Patients 0 8 403 411 O
aged 9 13 412 416 B-age
18 14 16 417 419 B-lower_bound
years 17 22 420 425 I-lower_bound
or 23 25 426 428 O
older 26 31 429 434 O

Patients 0 8 435 443 O
with 9 13 444 448 O
islet 14 19 449 454 B-cancer
cell 20 24 455 459 I-cancer
/ 24 25 459 460 I-cancer
neuroendocrine 25 39 460 474 I-cancer

adenocarcinoma 0 14 475 489 B-cancer
subtypes 15 23 490 498 O

adenosquamous 0 13 499 512 B-cancer
carcinoma 14 23 513 522 I-cancer

mucinous 0 8 523 531 B-cancer
carcinoma 9 18 532 541 I-cancer

papillary 0 9 542 551 B-cancer
cystic 10 16 552 558 I-cancer
neoplasm 17 25 559 567 I-cancer

receiving 0 9 568 577 O
3rd 10 13 578 581 B-treatment
- 13 14 581 582 I-treatment
line 14 18 582 586 I-treatment
palliative 19 29 587 597 I-treatment
chemotherapy 30 42 598 610 I-treatment

signet 0 6 611 617 B-cancer
ring 7 11 618 622 I-cancer
carcinoma 12 21 623 632 I-cancer

undifferentiated 0 16 633 649 O
/ 16 17 649 650 O
poorly 17 23 650 656 O
differentiated 24 38 657 671 O
carcinoma 39 48 672 681 B-cancer

